Continuation of Anti-osteoporotic Treatment 1 Year After Initial Administration

NCT06024148 | Unknown

• 1 other identifier: 38RC23.0179
• Study Type: observational
• Target: 250
• Locations: 0 countries
• Sites: N/A

Brief Summary

The aim of this observational study is to assess the obstacles and levers to the continuation of anti-osteoporotic treatment, and to identify those where action could be taken to improve the quality of care for fractured patients. The individual and collective stakes are high. Fracture is the most feared complication of osteoporosis. The current under-diagnosis and under-treatment of this chronic pathology exposes patients to a high risk of early re-fracture, with the associated morbidity and mortality. General practitioners have a major role to play in monitoring and coordinating patients' healthcare pathways. The aim of this study is to assess ways of improving osteoporosis management in order to improve quality of life and disability-free life expectancy for individual patients. The public health and economic stakes are equally high. It is by identifying the obstacles that prospective work on the key elements to be implemented could help optimize osteoporosis management.

Conditions

Osteoporosis Fracture

Keywords

antiosteoporotic treatment; professional practice assessment

Outcome Measures

Primary Outcomes (1)

• Evaluate the rate of continuation of anti-osteoporotic treatment at 1 year after initial administration following a severe osteoporotic fracture in patients aged 75 and over.

  Percentage of patients for whom anti-osteoporosis treatment was renewed 1 year after initial administration (between fracture occurrence and discharge from the geriatric department)

  Telephone data collection one year after Geriatric Rehabilitation Department stay

Secondary Outcomes (5)

• Determine the rate of introduction of anti-osteoporotic treatment during the patient's overall stay

  Medical records collected one year after Geriatric Rehabilitation Department stay

• Identify patient-related obstacles and levers to treatment renewal at 1 year after fracture

  Telephone data collection one year after Geriatric Rehabilitation Department stay

• Determine the obstacles and levers to the continuation of treatment at 1 year after a fracture, in relation to the treating physician.

  Telephone data collection one year after Geriatric Rehabilitation Department stay

• Determine the obstacles and levers to the continuation of treatment at 1 year for fractures related to the healthcare system

  Telephone data collection one year after Geriatric Rehabilitation Department stay

• Evaluation of the professional practices of general practitioners concerning the management of osteoporosis.

  Telephone data collection one year after Geriatric Rehabilitation Department stay of their patient

Study Arms (1)

patients hospitalized in the Geriatric Rehabilitation Department

patients aged 75 and over, admitted with a severe osteoporotic post-fracture, having received a first dose of antiosteoporotic treatment between the day of fracture and discharge from Geriatric Rehabilitation Department

Other: phone survey

Interventions

phone survey OTHER

patients complete a 10-minute telephone questionnaire on their osteoporosis management

patients hospitalized in the Geriatric Rehabilitation Department

Eligibility Criteria

• Age: 75 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

We will include the number of patients corresponding to the "patient flow" admitted to CMR's units of interest over one year, and, corresponding to the inclusion criteria (CMR welcomes 250 patients aged 75 and over to its geriatric units each year, all types of fractures combined; ¾ of patients are admitted for severe fractures).

You may qualify if:

• Hospitalization in CMR's Geriatric Rehabilitation Department between 01/06/2021 and 31/05/2022
• Age: 75 and over
• Admitted with severe post-fracture osteoporosis
• Having received a first dose of antiosteoporotic treatment between the day the fracture occurred and discharge from CMR (either in an inpatient unit prior to CMR, or at CMR)

You may not qualify if:

• Having objected to the use of his/her data for research purposes
• Subject under guardianship or deprived of liberty.
• Pathological fracture
• Anti-osteoporotic treatment prior to fracture
• year follow-up made impossible by lack of contact with patient, family or attending physician.

Sponsors & Collaborators

• University Hospital, Grenoble: lead

MeSH Terms

Conditions

Osteoporotic Fractures

Condition Hierarchy (Ancestors)

Fractures, Bone; Wounds and Injuries

Central Study Contacts

Sabine DREVET, Dr

CONTACT

04 76 76 66 06; sdrevet@chu-grenoble.fr

Magali ABADIE

CONTACT

mabadie@chu-grenoble.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 17, 2023
• First Posted: September 6, 2023
• Study Start: September 1, 2023
• Primary Completion: February 1, 2024
• Study Completion: September 1, 2024
• Last Updated: September 6, 2023

Record last verified: 2023-08